Non-HDL Cholesterol as a Metric of Good Quality of Care Opportunities and Challenges

被引：0

作者：

Virani, Salim S. ^{[1
,2
]}

机构：

[1] Michael E DeBakey VA Med Ctr, Hlth Policy & Qual Program, Hlth Serv Res & Dev Ctr Excellence, Houston, TX 77030 USA

[2] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA

来源：

TEXAS HEART INSTITUTE JOURNAL | 2011年 / 38卷 / 02期

关键词：

DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; RISK-FACTORS; LIPIDS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：160 / 162

页数：3

共 11 条

[1] Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels [J].

Ballantyne, CM ;

Andrews, TC ;

Hsia, JA ;

Kramer, JH ;

Shear, C .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :265-269

[2] The importance of non-HDL cholesterol reporting in lipid management [J].

Blaha, Michael J. ;

Blumenthal, Roger S. ;

Brinton, Eliot A. ;

Jacobson, Terry A. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (04) :267-273

[3] Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation [J].

Brunzell, John D. ;

Davidson, Michael ;

Furberg, Curt D. ;

Goldberg, Ronald B. ;

Howard, Barbara V. ;

Stein, James H. ;

Witztum, Joseph L. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) :1512-1524

[4] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[6] Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations [J].

Davidson, MH ;

Maki, KC ;

Pearson, TA ;

Pasternak, RC ;

Deedwania, PC ;

McKenney, JM ;

Fonarow, GC ;

Maron, DJ ;

Ansell, BJ ;

Clark, LT ;

Ballantyne, CM .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (04) :556-563

[7]

Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619

[8] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[9] Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment [J].

Kastelein, John J. P. ;

van der Steeg, Wim A. ;

Holme, Ingar ;

Gaffney, Michael ;

Cater, Nilo B. ;

Barter, Philip ;

Deedwania, Prakash ;

Olsson, Anders G. ;

Boekholdt, S. Matthijs ;

Demicco, David A. ;

Szarek, Michael ;

LaRosa, John C. ;

Pedersen, Terje R. ;

Grundy, Scott M. .

CIRCULATION, 2008, 117 (23) :3002-3009

[10] Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study [J].

Sattar, N ;

Williams, K ;

Sniderman, AD ;

D'Agostino, R ;

Haffner, SM .

CIRCULATION, 2004, 110 (17) :2687-2693

← 1 2 →